VERTEX PHARMACEUTICALS INC / MA Adjustments to Additional Paid in Capital, Other
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Adjustments to Additional Paid in Capital, Other of $6.70 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2013-11-07
- VERTEX PHARMACEUTICALS INC / MA adjustments to additional paid in capital, other for the quarter ending 2013-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA adjustments to additional paid in capital, other for the quarter ending 2012-09-30 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month |
|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.70M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $6.70M 10-Q · filed 2013-08-02 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |